← back to search

Pieter van Paassen

Maastricht University Medical Centre · NL
Area of research
Pulmonary and Respiratory Medicine · Nephrology
Research interest
Research interests include Vasculitis and related conditions, Renal Diseases and Glomerulopathies, Complement system in diseases, and Systemic Sclerosis and Related Diseases.
h-index
48
citations
8,839
works
225
NIH funding
primary concept
Medicine
email

Recent publications

Soluble immune checkpoints reflect immune activation and treatment response in high-risk systemic sclerosis patients treated with plasma exchange
Journal of Translational Autoimmunity 2026cited by 1position: contributordoi
Multistain multicompartment automatic segmentation in renal biopsies with thrombotic microangiopathies and other vasculopathies
Computerized Medical Imaging and Graphics 2025cited by 2position: middledoi
T-cell immunity in the experimental autoimmune vasculitis rat model.
2025cited by 0position: contributordoi
Long-term safety of hyaluronidase-facilitated subcutaneous immunoglobulin 10%: a European post-authorization study
Immunotherapy 2024cited by 5position: middledoi
Cytotoxic T Cells Drive Outcome in Inflammatory Dilated Cardiomyopathy.
2024cited by 4position: contributordoi
High Prevalence of Myositis-Specific and Associated Antibodies in Patients with Pulmonary Hypertension.
2024cited by 2position: contributordoi
High Prevalence of Myositis-Specific and Associated Antibodies in Patients with Pulmonary Hypertension
2024cited by 0position: contributordoi
Immune Responses 6 Months After mRNA-1273 COVID-19 Vaccination and the Effect of a Third Vaccination in Patients with Inborn Errors of Immunity
Journal of Clinical Immunology 2023cited by 20position: middledoi
Plasma Dephosphorylated-Uncarboxylated Matrix Gla-Protein in Systemic Sclerosis Patients: Biomarker Potential for Vascular Calcification and Inflammation.
2023cited by 7position: contributordoi
Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity
Journal of Allergy and Clinical Immunology 2022cited by 72position: middledoi
The anti-C5a antibody vilobelimab efficiently inhibits C5a in patients with severe COVID-19.
2022cited by 30position: contributordoi
Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseases
Annals of the Rheumatic Diseases 2022cited by 23position: middledoi
Annexin A1 Is Associated with Adverse Clinical Outcomes in Patients with COVID-19.
2022cited by 7position: contributordoi
Adult-onset autoinflammation caused by somatic mutations in UBA1: A Dutch case series of patients with VEXAS
Journal of Allergy and Clinical Immunology 2021cited by 208position: middledoi
The Syndromes of Thrombotic Microangiopathy: A Critical Appraisal on Complement Dysregulation.
2021cited by 25position: contributordoi
Neutrophils and Contact Activation of Coagulation as Potential Drivers of COVID-19
Circulation 2020cited by 105position: contributordoi
Cardiac Inflammation Impedes Response to Cardiac Resynchronization Therapy in Patients With Idiopathic Dilated Cardiomyopathy
Circulation: Arrhythmia and Electrophysiology 2020cited by 9position: contributordoi
Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis
Nature Reviews Rheumatology 2017cited by 447position: middledoi
A multicentre study to improve clinical interpretation of proteinase-3 and myeloperoxidase anti-neutrophil cytoplasmic antibodies
Lara D. Veeken 2017cited by 62position: middledoi
Detection of antineutrophil cytoplasmic antibodies (ANCAs): a multicentre European Vasculitis Study Group (EUVAS) evaluation of the value of indirect immunofluorescence (IIF) versus antigen-specific immunoassays
Annals of the Rheumatic Diseases 2016cited by 194position: middledoi
Evaluation of automated multi-parametric indirect immunofluorescence assays to detect anti-neutrophil cytoplasmic antibodies (ANCA) in granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA)
Autoimmunity Reviews 2016cited by 65position: middledoi
Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: Eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitis
International Journal of Cardiology 2015cited by 141position: middledoi
Evaluation of Anti-PLA2R1 as Measured by a Novel ELISA in Patients With Idiopathic Membranous Nephropathy
American Journal of Clinical Pathology 2014cited by 71position: middledoi
Anti–Phospholipase A2 Receptor Antibodies and Malignancy in Membranous Nephropathy
American Journal of Kidney Diseases 2013cited by 58position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jan Damoiseaux · Maine Farmland Trust12 papers (2014–2026) · 11 papers (2020–2026) · 6 papers (2022–2026) · 4 papers (2016–2017)Xavier Bossuyt · KU Leuven4 papers (2016–2017)Daniël Blockmans · Universitair Ziekenhuis Leuven4 papers (2016–2017)Elena Csernok · University of Tübingen4 papers (2016–2017)Niels Rasmussen · University of Rochester Medical Center4 papers (2016–2017)Sjoerd A.M.E.G. Timmermans · Vrije Universiteit Amsterdam3 papers (2013–2025)Pieter Vermeersch · Universitair Ziekenhuis Leuven3 papers (2016–2017)Sjoerd A.M.E.G. Timmermans · Maastricht University3 papers (2020–2022) · 2 papers (2016–2017)David J. Salant · Boston University2 papers (2013–2014)Bernhard Hellmich · University of Tübingen2 papers (2016–2017)Rivka Ayalon · Boston Medical Center2 papers (2013–2014)Job Verdonschot · Anna Needs Neuroblastoma Answers2 papers (2020–2024) · 2 papers (2020–2024) · 2 papers (2022–2022)Leon J Schurgers · University Medical Center Groningen2 papers (2023–2026)Stephane Heymans · Cardiovascular Institute Hospital2 papers (2020–2024)